Cargando…

LINC00586 Represses ASXL1 Expression Thus Inducing Epithelial-To-Mesenchymal Transition of Colorectal Cancer Cells Through LSD1-Mediated H3K4me2 Demethylation

Colorectal cancer (CRC) is a major public health problem on a global scale by virtue of its relatively high incidence. The transition of tumor cells from an epithelial to a mesenchymal-like phenotype, so-called epithelial-to-mesenchymal transition (EMT), is a key hallmark of human cancer metastasis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fengting, Ma, Xiaofang, Bian, Xiyun, Zhang, Chunyan, Liu, Xiaozhi, Liu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108668/
https://www.ncbi.nlm.nih.gov/pubmed/35586041
http://dx.doi.org/10.3389/fphar.2022.887822
_version_ 1784708753109549056
author Liu, Fengting
Ma, Xiaofang
Bian, Xiyun
Zhang, Chunyan
Liu, Xiaozhi
Liu, Qiang
author_facet Liu, Fengting
Ma, Xiaofang
Bian, Xiyun
Zhang, Chunyan
Liu, Xiaozhi
Liu, Qiang
author_sort Liu, Fengting
collection PubMed
description Colorectal cancer (CRC) is a major public health problem on a global scale by virtue of its relatively high incidence. The transition of tumor cells from an epithelial to a mesenchymal-like phenotype, so-called epithelial-to-mesenchymal transition (EMT), is a key hallmark of human cancer metastasis, including CRC. Understanding the signaling events that initiate this phenotypic switch may provide opportunities to limit the metastasis of CRC. In this study, we aim to identify long non-coding RNA (lncRNA) mediated epigenetic regulation under the context of CRC. 54 paired samples of tumor tissues and surrounding non-tumor tissues were collected from CRC patients. Cultured human CRC cells HCT116 and LoVo were assayed for their viability and migration using CCK-8 tests and transwell migration assays. The expression of EMT-specific markers (E-cadherin, N-cadherin and vimentin) was analyzed biochemically by RT-qPCR and immunoblot analyses. Interaction among LINC00586, LSD1, and ASXL1 was determined by RNA immunoprecipitation and chromatin immunoprecipitation. In vivo analysis of LINC00586 was performed in nude mice xenografted with HCT116 cells. LINC00586 was overexpressed in CRC tissues and associated with patient survival. LINC00586 knockdown repressed HCT116 and LoVo cell viability, migration, their phenotypic switch from epithelial to a mesenchymal, and tumorigenesis in vivo. We demonstrated LINC00586 recruited the LSD1 into the ASXL1 promoter region and epigenetically silenced the ASXL1 expression. An ASXL1 gene resisting to LINC00586 attack was demonstrated in cultured HCT116 and LoVo cells and mouse xenograft models of human CRC. Overall, discovery of the LINC00586/LSD1/ASXL1 axis partially explains epigenetic mechanism regulating EMT in CRC, providing a therapeutic target to limit CRC metastasis.
format Online
Article
Text
id pubmed-9108668
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91086682022-05-17 LINC00586 Represses ASXL1 Expression Thus Inducing Epithelial-To-Mesenchymal Transition of Colorectal Cancer Cells Through LSD1-Mediated H3K4me2 Demethylation Liu, Fengting Ma, Xiaofang Bian, Xiyun Zhang, Chunyan Liu, Xiaozhi Liu, Qiang Front Pharmacol Pharmacology Colorectal cancer (CRC) is a major public health problem on a global scale by virtue of its relatively high incidence. The transition of tumor cells from an epithelial to a mesenchymal-like phenotype, so-called epithelial-to-mesenchymal transition (EMT), is a key hallmark of human cancer metastasis, including CRC. Understanding the signaling events that initiate this phenotypic switch may provide opportunities to limit the metastasis of CRC. In this study, we aim to identify long non-coding RNA (lncRNA) mediated epigenetic regulation under the context of CRC. 54 paired samples of tumor tissues and surrounding non-tumor tissues were collected from CRC patients. Cultured human CRC cells HCT116 and LoVo were assayed for their viability and migration using CCK-8 tests and transwell migration assays. The expression of EMT-specific markers (E-cadherin, N-cadherin and vimentin) was analyzed biochemically by RT-qPCR and immunoblot analyses. Interaction among LINC00586, LSD1, and ASXL1 was determined by RNA immunoprecipitation and chromatin immunoprecipitation. In vivo analysis of LINC00586 was performed in nude mice xenografted with HCT116 cells. LINC00586 was overexpressed in CRC tissues and associated with patient survival. LINC00586 knockdown repressed HCT116 and LoVo cell viability, migration, their phenotypic switch from epithelial to a mesenchymal, and tumorigenesis in vivo. We demonstrated LINC00586 recruited the LSD1 into the ASXL1 promoter region and epigenetically silenced the ASXL1 expression. An ASXL1 gene resisting to LINC00586 attack was demonstrated in cultured HCT116 and LoVo cells and mouse xenograft models of human CRC. Overall, discovery of the LINC00586/LSD1/ASXL1 axis partially explains epigenetic mechanism regulating EMT in CRC, providing a therapeutic target to limit CRC metastasis. Frontiers Media S.A. 2022-05-02 /pmc/articles/PMC9108668/ /pubmed/35586041 http://dx.doi.org/10.3389/fphar.2022.887822 Text en Copyright © 2022 Liu, Ma, Bian, Zhang, Liu and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liu, Fengting
Ma, Xiaofang
Bian, Xiyun
Zhang, Chunyan
Liu, Xiaozhi
Liu, Qiang
LINC00586 Represses ASXL1 Expression Thus Inducing Epithelial-To-Mesenchymal Transition of Colorectal Cancer Cells Through LSD1-Mediated H3K4me2 Demethylation
title LINC00586 Represses ASXL1 Expression Thus Inducing Epithelial-To-Mesenchymal Transition of Colorectal Cancer Cells Through LSD1-Mediated H3K4me2 Demethylation
title_full LINC00586 Represses ASXL1 Expression Thus Inducing Epithelial-To-Mesenchymal Transition of Colorectal Cancer Cells Through LSD1-Mediated H3K4me2 Demethylation
title_fullStr LINC00586 Represses ASXL1 Expression Thus Inducing Epithelial-To-Mesenchymal Transition of Colorectal Cancer Cells Through LSD1-Mediated H3K4me2 Demethylation
title_full_unstemmed LINC00586 Represses ASXL1 Expression Thus Inducing Epithelial-To-Mesenchymal Transition of Colorectal Cancer Cells Through LSD1-Mediated H3K4me2 Demethylation
title_short LINC00586 Represses ASXL1 Expression Thus Inducing Epithelial-To-Mesenchymal Transition of Colorectal Cancer Cells Through LSD1-Mediated H3K4me2 Demethylation
title_sort linc00586 represses asxl1 expression thus inducing epithelial-to-mesenchymal transition of colorectal cancer cells through lsd1-mediated h3k4me2 demethylation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108668/
https://www.ncbi.nlm.nih.gov/pubmed/35586041
http://dx.doi.org/10.3389/fphar.2022.887822
work_keys_str_mv AT liufengting linc00586repressesasxl1expressionthusinducingepithelialtomesenchymaltransitionofcolorectalcancercellsthroughlsd1mediatedh3k4me2demethylation
AT maxiaofang linc00586repressesasxl1expressionthusinducingepithelialtomesenchymaltransitionofcolorectalcancercellsthroughlsd1mediatedh3k4me2demethylation
AT bianxiyun linc00586repressesasxl1expressionthusinducingepithelialtomesenchymaltransitionofcolorectalcancercellsthroughlsd1mediatedh3k4me2demethylation
AT zhangchunyan linc00586repressesasxl1expressionthusinducingepithelialtomesenchymaltransitionofcolorectalcancercellsthroughlsd1mediatedh3k4me2demethylation
AT liuxiaozhi linc00586repressesasxl1expressionthusinducingepithelialtomesenchymaltransitionofcolorectalcancercellsthroughlsd1mediatedh3k4me2demethylation
AT liuqiang linc00586repressesasxl1expressionthusinducingepithelialtomesenchymaltransitionofcolorectalcancercellsthroughlsd1mediatedh3k4me2demethylation